Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer

Immune checkpoint blockade (ICB) has been recognized as a promising immunotherapy for colorectal cancer (CRC); however, most patients have little or no clinical benefit. This study aimed to develop a novel cancer-immunity cycle–based signature to stratify prognosis of patients with CRC and predict e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yufang, Zhang, Rixin, Zong, Jinbao, Wang, Weiqi, Zhou, Mingxuan, Yan, Zheng, Li, Tiegang, Gan, Wenqiang, Lv, Silin, Zeng, Zifan, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193226/
https://www.ncbi.nlm.nih.gov/pubmed/35711437
http://dx.doi.org/10.3389/fimmu.2022.892512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193226/
https://www.ncbi.nlm.nih.gov/pubmed/35711437
http://dx.doi.org/10.3389/fimmu.2022.892512

Ejemplares similares